Why the study?
To investigate the contribution of CaMKIIbeta signaling to the calpain 3-deficient phenotype in limb girdle muscular dystrophy R1.
Does overexpression of constitutively active CaMK2b improve oxidative metabolism and functional performance in calpain 3 knockout models of LGMDR1?
Population
Camk2b cKO mice, C3KO mice, and LGMDR1 patient biopsies
Comparison
Loss-of-function and gain-of-function CaMK2b models
Design
Preclinical animal and human biopsy study
Key result
Overexpression of constitutively active Camk2b in calpain 3 knockout muscles enhanced oxidative metabolism and improved functional performance, highlighting its therapeutic potential for LGMDR1.
Authors
Loading...
May improve metabolic outcomes in LGMDR1 models; leaves open translation of CaMKIIβ targeting to patients.
Does overexpression of constitutively active CaMK2b improve oxidative metabolism and functional performance in calpain 3 knockout models of LGMDR1?
Blunted CaMKIIβ signaling contributes to metabolic insufficiency in LGMDR1, and targeting this pathway may ameliorate disease features.
Kramerova et al. (2026) studied Limb girdle muscular dystrophy R1 (LGMDR1). Loss-of-function (Camk2b cKO) and gain-of-function (overexpression of constitutively active CaMK2b) vs. C3KO muscles / wild-type was evaluated on Muscle phenotype, oxidative metabolism, and functional performance. Overexpression of constitutively active Camk2b in calpain 3 knockout muscles enhanced oxidative metabolism and improved functional performance, highlighting its therapeutic potential for LGMDR1.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: